(2S)-2-Hydroxybutanedioic acid
Common Name: |
(2S)-2-Hydroxybutanedioic acid |
IUPAC Name: |
(2S)-2-hydroxybutanedioic acid |
Molecular Formula: |
C4H6O5 |
SMILES: |
C([C@@H](C(=O)O)O)C(=O)O |
Inchi: |
1S/C4H6O5/c5-2(4(8)9)1-3(6)7/h2,5H,1H2,(H,6,7)(H,8,9)/t2-/m0/s1 |
Inchi Key: |
BJEPYKJPYRNKOW-REOHCLBHSA-N |
Cas No: |
97-67-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
4 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
134.09 |
Mass (g/mol) |
134.022 |
Molar Refractivity |
26.05 |
Net Charge |
-2 |
HBD |
3 |
HBA |
5 |
Rt Bonds |
3 |
Rings |
|
TPSA |
94.83 |
Hetero Atoms |
5 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
99.00 to 100.00 |
Boiling Point (°C@760.00mm Hg) |
140.00 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.50 |
LogP |
-1.093 |
iLOGP |
-0.01 |
XLOGP3 |
-1.26 |
WLOGP |
-1.09 |
MLOGP |
-1.37 |
ESOL Log S |
0.32 |
ESOL Solubility (mg/ml) |
280 |
ESOL Solubility (mol/l) |
2.09 |
ESOL Class: esol_class |
Highly soluble |
Ali Log S |
-0.24 |
Ali Solubility (mg/ml) |
78 |
Ali Solubility (mol/l) |
0.58 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
1.53 |
Silicos-IT Solubility (mg/ml) |
4510 |
Silicos-IT Solubility (mol/l) |
33.7 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-8.01 |
Bioavailability Score |
0.56 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.233 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
0.844 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |